SUPPLEMENTAL AGREEMENTSupplemental Agreement • April 1st, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
This Supplemental Agreement (this "Supplemental Agreement"), dated as of March 15 2002, is made and entered into by and among Inhale Therapeutic Systems, Inc. ("Inhale") and Alliance Pharmaceutical Corporation ("Alliance") (collectively referred to as the "Parties").
